Evidence map›Paper›PMID 37079304›Full record

ArticleJAMA network open2023

Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022.

Robyn Mitchell, Joelle Cayen, Nisha Thampi, Charles Frenette, Jessica Bartoszko, Kelly Baekyung Choi, Jeannette L Comeau, John Conly, Chelsey Ellis, Jennifer Ellison and 20 more

Erratum issuedAbstract read
In one paragraph

Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Error in Methods.JAMA network open · 2023
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Robyn MitchellCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Joelle CayenCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Nisha ThampiDepartment of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Charles FrenetteDivision of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
Jessica BartoszkoCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Kelly Baekyung ChoiCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Jeannette L ComeauDepartment of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.
John ConlyDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Chelsey EllisDepartment of Laboratory Medicine, The Moncton Hospital, Moncton, New Brunswick, Canada.
Jennifer EllisonInfection, Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada.
John EmbilInfection Prevention and Control, Health Sciences Centre, Winnipeg, Manitoba, Canada.
Gerald EvansDivision of Infectious Diseases, Queen's University, Kingston, Ontario, Canada.
Lynn JohnstonDivision of Infectious Diseases, Department of Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
Jennie JohnstoneInfection Prevention and Control, Sinai Health, Toronto, Ontario, Canada.
Kevin C KatzInfection Prevention and Control, North York General Hospital, Toronto, Ontario, Canada.
Pamela KibseyDepartment of Pathology and Laboratory Medicine, Royal Jubilee Hospital, Victoria, British Columbia, Canada.
Bonita LeeDepartment of Pediatrics, Stollery Children's Hospital, Edmonton, Alberta, Canada.
Marie-Astrid LefebvreMontreal Children's Hospital, McGill University Health Centre, Montréal, Québec, Canada.
Yves LongtinInfection Prevention and Control, SMBD Jewish General Hospital, Montréal, Québec, Canada.
Allison McGeerInfection Prevention and Control, Sinai Health, Toronto, Ontario, Canada.
Dominik MertzDivision of Infectious Diseases, Department of Medicine, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Jessica MinionDepartment of Laboratory Medicine, Saskatchewan Health Authority, Regina, Saskatchewan, Canada.
Wallis RudnickCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Anada SilvaCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Stephanie W SmithFaculty of Medicine, University of Alberta Hospital, Edmonton, Alberta, Canada.
Jocelyn A SrigleyInfection Prevention and Control, BC Women's and BC Children's Hospital, Vancouver, British Columbia, Canada.
Kathryn N SuhInfection Prevention and Control, The Ottawa Hospital, Ottawa, Ontario, Canada.
Jen TomlinsonInfection Prevention and Control, Health Sciences Centre, Winnipeg, Manitoba, Canada.
Alice WongDivision of Infectious Diseases, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, Canada.
Linda PeludeCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Trends in COVID-19 severe outcomes have significant implications for the health care system and are key to informing public health measures. However, data summarizing trends in severe outcomes among patients hospitalized with COVID-19 in Canada are not well described. Objective: To describe trends in severe outcomes among patients hospitalized with COVID-19 during the first 2 years of the COVID-19 pandemic. Design, Setting, and Participants: Active prospective surveillance in this cohort study was conducted from March 15, 2020, to May 28, 2022, at a sentinel network of 155 acute care hospitals across Canada. Participants included adult (aged ≥18 years) and pediatric (aged 0-17 years) patients hospitalized with laboratory-confirmed COVID-19 at a Canadian Nosocomial Infection Surveillance Program (CNISP)-participating hospital. Exposures: COVID-19 waves, COVID-19 vaccination status, and age group. Main Outcomes and Measures: The CNISP collected weekly aggregate data on the following severe outcomes: hospitalization, admission to an intensive care unit (ICU), receipt of mechanical ventilation, receipt of extracorporeal membrane oxygenation, and all-cause in-hospital death. Results: Among 1 513 065 admissions, the proportion of adult (n = 51 679) and pediatric (n = 4035) patients hospitalized with laboratory-confirmed COVID-19 was highest in waves 5 and 6 of the pandemic compared with waves 1 to 4 (77.3 vs 24.7 per 1000 patient admissions). Despite this, the proportion of patients with positive test results for COVID-19 who were admitted to an ICU, received mechanical ventilation, received extracorporeal membrane oxygenation, and died were each significantly lower in waves 5 and 6 when compared with waves 1 through 4. Admission to the ICU and in-hospital all-cause death rates were significantly higher among those who were unvaccinated against COVID-19 when compared with those who were fully vaccinated (incidence rate ratio, 4.3 and 3.9, respectively) or fully vaccinated with an additional dose (incidence rate ratio, 12.2 and 15.1, respectively). Conclusions and Relevance: The findings of this cohort study of patients hospitalized with laboratory-confirmed COVID-19 suggest that COVID-19 vaccination is important to reduce the burden on the Canadian health care system as well as severe outcomes associated with COVID-19.

Indexed as

COVID-19Cross InfectionAdolescentAdultCanadaChildCohort StudiesCOVID-19 VaccinesHospital MortalityHumansPandemicsProspective StudiesSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID37079304
PMCPMC10119741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.